CASSAVA SCIENCES INC Quarterly Debt-to-equity in % from Q1 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cassava Sciences Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q4 2023.
  • Cassava Sciences Inc Debt-to-equity for the quarter ending December 31, 2023 was 9.41 %, a 159% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q4 2023 9.41 +5.78 +159% Dec 31, 2023
Q3 2023 7.4 +3.27 +79.1% Sep 30, 2023
Q2 2023 5.91 +2.26 +61.9% Jun 30, 2023
Q1 2023 4.59 +1.55 +51% Mar 31, 2023
Q4 2022 3.63 +1.1 +43.6% Dec 31, 2022
Q3 2022 4.13 +2.34 +130% Sep 30, 2022
Q2 2022 3.65 +1.99 +120% Jun 30, 2022
Q1 2022 3.04 +1.21 +66.2% Mar 31, 2022
Q4 2021 2.52 -1.1 -30.4% Dec 31, 2021
Q3 2021 1.8 -3.75 -67.6% Sep 30, 2021
Q2 2021 1.66 -3.73 -69.2% Jun 30, 2021
Q1 2021 1.83 -3.58 -66.2% Mar 31, 2021
Q4 2020 3.62 -2 -35.6% Dec 31, 2020
Q3 2020 5.54 +0.92 +19.9% Sep 30, 2020
Q2 2020 5.39 +1.02 +23.3% Jun 30, 2020
Q1 2020 5.41 -0.04 -0.74% Mar 31, 2020
Q4 2019 5.62 -0.22 -3.76% Dec 31, 2019
Q3 2019 4.62 -3.71 -44.6% Sep 30, 2019
Q2 2019 4.38 -6.11 -58.2% Jun 30, 2019
Q1 2019 5.44 -3.29 -37.7% Mar 31, 2019
Q4 2018 5.85 -2.03 -25.8% Dec 31, 2018
Q3 2018 8.32 +2.4 +40.5% Sep 30, 2018
Q2 2018 10.5 +3.65 +53.4% Jun 30, 2018
Q1 2018 8.74 +1.53 +21.2% Mar 31, 2018
Q4 2017 7.88 -1.44 -15.5% Dec 31, 2017
Q3 2017 5.93 -4.3 -42.1% Sep 30, 2017
Q2 2017 6.84 -2.59 -27.5% Jun 30, 2017
Q1 2017 7.21 -1.12 -13.5% Mar 31, 2017
Q4 2016 9.32 +3.36 +56.4% Dec 31, 2016
Q3 2016 10.2 +5.85 +134% Sep 30, 2016
Q2 2016 9.43 +5.41 +135% Jun 30, 2016
Q1 2016 8.32 +4.55 +120% Mar 31, 2016
Q4 2015 5.96 +2.09 +54.1% Dec 31, 2015
Q3 2015 4.37 +0.16 +3.8% Sep 30, 2015
Q2 2015 4.01 -24.1 -85.7% Jun 30, 2015
Q1 2015 3.78 -61.5 -94.2% Mar 31, 2015
Q4 2014 3.86 -129 -97.1% Dec 31, 2014
Q3 2014 4.22 -290 -98.6% Sep 30, 2014
Q2 2014 28.1 -169 -85.7% Jun 30, 2014
Q1 2014 65.3 -86.2 -56.9% Mar 31, 2014
Q4 2013 133 +6.73 +5.33% Dec 31, 2013
Q3 2013 294 +184 +166% Sep 30, 2013
Q2 2013 197 +78.7 +66.7% Jun 30, 2013
Q1 2013 152 +25.1 +19.9% Mar 31, 2013
Q4 2012 126 Dec 31, 2012
Q3 2012 110 Sep 30, 2012
Q2 2012 118 Jun 30, 2012
Q1 2012 126 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.